Advisors Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,733
| Closed | -$43.1K | – | 1525 |
|
|
2025
Q1 | $43.1K | Sell |
1,733
-896
| -34% | -$22.3K | ﹤0.01% | 1300 |
|
|
2024
Q4 | $49.5K | Sell |
2,629
-2,179
| -45% | -$41.1K | ﹤0.01% | 1318 |
|
|
2024
Q3 | $72.4K | Sell |
4,808
-399
| -8% | -$6.01K | ﹤0.01% | 1265 |
|
|
2024
Q2 | $149K | Sell |
5,207
-1,081
| -17% | -$30.9K | ﹤0.01% | 1156 |
|
|
2024
Q1 | $184K | Sell |
6,288
-283
| -4% | -$8.27K | ﹤0.01% | 1148 |
|
|
2023
Q4 | $222K | Sell |
6,571
-100
| -1% | -$3.37K | ﹤0.01% | 1097 |
|
|
2023
Q3 | $205K | Buy |
6,671
+1,840
| +38% | +$56.5K | ﹤0.01% | 1107 |
|
|
2023
Q2 | $194K | Buy |
4,831
+710
| +17% | +$28.5K | ﹤0.01% | 1124 |
|
|
2023
Q1 | $168K | Buy |
4,121
+462
| +13% | +$18.9K | ﹤0.01% | 1146 |
|
|
2022
Q4 | $141K | Buy |
3,659
+2,402
| +191% | +$92.7K | ﹤0.01% | 1183 |
|
|
2022
Q3 | $67K | Buy |
1,257
+309
| +33% | +$16.5K | ﹤0.01% | 1325 |
|
|
2022
Q2 | $55K | Buy |
+948
| New | +$55K | ﹤0.01% | 1361 |
|